1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Vision Disorders Global Clinical Trials Review, H2, 2015

Vision Disorders Global Clinical Trials Review, H2, 2015

Summary

GlobalData's clinical trial report, “Vision Disorders Global Clinical Trials Review, H2, 2015" provides an overview of Vision Disorders clinical trials scenario. This report provides top line data relating to the clinical trials on Vision Disorders. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Global Data Clinical Trial Reports are generated using Global Data’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table Of Contents

Vision Disorders Global Clinical Trials Review, H2, 2015
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Vision Disorders 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Vision Disorders to Ophthalmology Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Vision Disorders to Ophthalmology Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Vision Disorders 25
Subjects Recruited Over a Period of Time 27
Clinical Trials by Sponsor Type 28
Prominent Sponsors 29
Top Companies Participating in Vision Disorders Therapeutics Clinical Trials 30
Prominent Drugs 31
Latest Clinical Trials News on Vision Disorders 32
Jun 29, 2015: NightstaRx and The University of Alberta announce the start of the first Canadian Gene Therapy Study to Treat Choroideremia 32
Clinical Trial Profiles 33
Clinical Trial Overview of Top Companies 33
Novartis AG 33
Clinical Trial Overview of Novartis AG 33
ThromboGenics NV 34
Clinical Trial Overview of ThromboGenics NV 34
Celerion, Inc. 35
Clinical Trial Overview of Celerion, Inc. 35
C. H. Boehringer Sohn AG and Co. KG 36
Clinical Trial Overview of C. H. Boehringer Sohn AG and Co. KG 36
Allegro Ophthalmics, LLC 37
Clinical Trial Overview of Allegro Ophthalmics, LLC 37
Beyond Blue Limited 38
Clinical Trial Overview of Beyond Blue Limited 38
Bayer AG 39
Clinical Trial Overview of Bayer AG 39
Asociacion para Evitar la Ceguera en Mexico I.A.P. 40
Clinical Trial Overview of Asociacion para Evitar la Ceguera en Mexico I.A.P. 40
Alcon, Inc. 41
Clinical Trial Overview of Alcon, Inc. 41
Alberta Innovates- Health Solutions 42
Clinical Trial Overview of Alberta Innovates- Health Solutions 42
Clinical Trial Overview of Top Institutes / Government 43
U.S. Department of Veterans Affairs 43
Clinical Trial Overview of U.S. Department of Veterans Affairs 43
National Eye Institute 44
Clinical Trial Overview of National Eye Institute 44
Postgraduate Institute of Medical Education and Research 45
Clinical Trial Overview of Postgraduate Institute of Medical Education and Research 45
Case Western Reserve University 46
Clinical Trial Overview of Case Western Reserve University 46
Charite - Universitatsmedizin Berlin 47
Clinical Trial Overview of Charite - Universitatsmedizin Berlin 47
Dong Rae Bong Seng Hospital 48
Clinical Trial Overview of Dong Rae Bong Seng Hospital 48
Jaeb Center for Health Research 49
Clinical Trial Overview of Jaeb Center for Health Research 49
L.V. Prasad Eye Institute 50
Clinical Trial Overview of L.V. Prasad Eye Institute 50
Moorfields Eye Hospital NHS Foundation Trust 51
Clinical Trial Overview of Moorfields Eye Hospital NHS Foundation Trust 51
Neurological Institute of Colombia 52
Clinical Trial Overview of Neurological Institute of Colombia 52
Five Key Clinical Profiles 53
Appendix 96
Abbreviations 96
Definitions 96
Research Methodology 97
Secondary Research 97
About GlobalData 98
Contact Us 98
Disclaimer 98
Source 99

List of Tables
Vision Disorders Therapeutics, Global, Clinical Trials by Region, 2015* 7
Vision Disorders Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Vision Disorders Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Vision Disorders Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015* 10
Vision Disorders Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11
Vision Disorders Therapeutics Clinical Trials, North America, Top Countries, 2015* 12
Vision Disorders Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015* 13
Vision Disorders Therapeutics Clinical Trials, Central and South America, Top Countries, 2015* 14
Proportion of Vision Disorders to Ophthalmology Clinical Trials, G7 Countries (%), 2015* 15
Vision Disorders Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
Vision Disorders Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17
Proportion of Vision Disorders to Ophthalmology Clinical Trials, E7 Countries (%), 2015* 18
Vision Disorders Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19
Vision Disorders Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20
Vision Disorders Therapeutics, Global, Clinical Trials by Phase, 2015* 21
Vision Disorders Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 22
Vision Disorders Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23
Vision Disorders Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24
Vision Disorders Therapeutics, Global, Withdrawn Clinical Trials, 2015* 25
Vision Disorders Therapeutics, Global, Terminated Clinical Trials, 2015* 26
Vision Disorders Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 27
Vision Disorders Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 28
Vision Disorders Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 29
Vision Disorders Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 30
Vision Disorders Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 31
Vision Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2015* 33
Vision Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by ThromboGenics NV, 2015* 34
Vision Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by Celerion, Inc., 2015* 35
Vision Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by C. H. Boehringer Sohn AG and Co. KG, 2015* 36
Vision Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by Allegro Ophthalmics, LLC, 2015* 37
Vision Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by Beyond Blue Limited, 2015* 38
Vision Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer AG, 2015* 39
Vision Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by Asociacion para Evitar la Ceguera en Mexico I.A.P., 2015* 40
Vision Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by Alcon, Inc., 2015* 41
Vision Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by Alberta Innovates- Health Solutions, 2015* 42
Vision Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by U.S. Department of Veterans Affairs, 2015* 43
Vision Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by National Eye Institute, 2015* 44
Vision Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by Postgraduate Institute of Medical Education and Research, 2015* 45
Vision Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by Case Western Reserve University, 2015* 46
Vision Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by Charite - Universitatsmedizin Berlin, 2015* 47
Vision Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by Dong Rae Bong Seng Hospital , 2015* 48
Vision Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by Jaeb Center for Health Research, 2015* 49
Vision Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by L.V. Prasad Eye Institute, 2015* 50
Vision Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by Moorfields Eye Hospital NHS Foundation Trust, 2015* 51
Vision Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by Neurological Institute of Colombia, 2015* 52

List of Figures
Vision Disorders Therapeutics, Global, Clinical Trials by Region (%), 2015* 7
Vision Disorders Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Vision Disorders Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Vision Disorders Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015* 10
Vision Disorders Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11
Vision Disorders Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 12
Vision Disorders Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2015* 14
Proportion of Vision Disorders to Ophthalmology Clinical Trials, G7 Countries (%), 2015* 15
Vision Disorders Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
Vision Disorders Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17
Proportion of Vision Disorders to Ophthalmology Clinical Trials, E7 Countries (%), 2015* 18
Vision Disorders Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19
Vision Disorders Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20
Vision Disorders Therapeutics, Global, Clinical Trials by Phase (%), 2015* 21
Vision Disorders Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 22
Vision Disorders Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23
Vision Disorders Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24
Vision Disorders Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 27
Vision Disorders Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 28
Vision Disorders Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 29
Vision Disorders Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 30
Vision Disorders Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 31
GlobalData Methodology 97

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

  • $ 5650
  • Industry report
  • August 2016
  • by MarketsandMarkets

The global clinical trial management system (CTMS) market is estimated to grow at a CAGR of 11.5% from 2016 to 2021, to reach USD 920.0 billion by 2021. The adoption of CTMS software is on the rise across ...

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global CRO services market is estimated to grow at a CAGR of 7.4% from 2016 to 2021, to reach USD 41.86 billion by 2021 from USD 29.29 billion in 2016. Growth in this market is primarily attributed ...

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • November 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Clinical Trial Management System (CTMS) market is expected to grow from $493.58 million in 2015 to reach $1118.58 million by 2022 with a CAGR of 12.4%. Huge research ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.